These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38352864)

  • 1. High ANO1 expression is a prognostic factor and correlated with an immunosuppressive tumor microenvironment in pancreatic cancer.
    Zhang G; Shu Z; Yu J; Li J; Yi P; Wu B; Deng D; Yan S; Li Y; Ren D; Hou Y; Lan C
    Front Immunol; 2024; 15():1341209. PubMed ID: 38352864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of tumour-infiltrating lymphocytes and cancer-associated fibroblasts in patients with pancreatic adenocarcinoma of the body and tail undergoing resection.
    Delayre T; Guilbaud T; Resseguier N; Mamessier E; Rubis M; Moutardier V; Fara R; Berdah SV; Garcia S; Birnbaum DJ
    Br J Surg; 2020 May; 107(6):720-733. PubMed ID: 31960955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma.
    Kiryu S; Ito Z; Suka M; Bito T; Kan S; Uchiyama K; Saruta M; Hata T; Takano Y; Fujioka S; Misawa T; Yamauchi T; Yanagisawa H; Sato N; Ohkusa T; Sugiyama H; Koido S
    BMC Cancer; 2021 Nov; 21(1):1197. PubMed ID: 34758773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
    Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
    Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ANO1 in tumors and tumor immunity.
    Li H; Yu Z; Wang H; Wang N; Sun X; Yang S; Hua X; Liu Z
    J Cancer Res Clin Oncol; 2022 Aug; 148(8):2045-2068. PubMed ID: 35471604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of ANO1 expression in cancers.
    Zhang C; Li H; Gao J; Cui X; Yang S; Liu Z
    Medicine (Baltimore); 2021 Jan; 100(4):e24525. PubMed ID: 33530281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis.
    Orhan A; Vogelsang RP; Andersen MB; Madsen MT; Hölmich ER; Raskov H; Gögenur I
    Eur J Cancer; 2020 Jun; 132():71-84. PubMed ID: 32334338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-Associated Fibroblasts Affect Intratumoral CD8
    Kato T; Noma K; Ohara T; Kashima H; Katsura Y; Sato H; Komoto S; Katsube R; Ninomiya T; Tazawa H; Shirakawa Y; Fujiwara T
    Clin Cancer Res; 2018 Oct; 24(19):4820-4833. PubMed ID: 29921731
    [No Abstract]   [Full Text] [Related]  

  • 9. Implication of IL6-positive Cancer-associated Fibroblasts in Merkel Cell Carcinoma Pathogenesis: A Possible Modulator of Immune Microenvironment.
    Zheng Z; Yoo DS; Li S; Pei M; Lee SG; Kim JY; Chung KY; Roh MR
    Anticancer Res; 2022 Sep; 42(9):4359-4369. PubMed ID: 36039447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High level of ANO1 promotes pancreatic cancer growth in concert with oncogenic KRAS.
    Zhang L; Wang H; Guo J; Xu H; Qian Y; Sun M
    Mol Biol Rep; 2023 Apr; 50(4):3297-3307. PubMed ID: 36715788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
    Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
    Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Evaluation of Tumor-Infiltrating CD8 + and FoxP3 + Lymphocytes Provides Accurate Prognosis in Stage IA Lung Adenocarcinoma.
    Kinoshita F; Takada K; Yamada Y; Oku Y; Kosai K; Ono Y; Tanaka K; Wakasu S; Oba T; Osoegawa A; Tagawa T; Shimokawa M; Oda Y; Mori M
    Ann Surg Oncol; 2020 Jun; 27(6):2102-2109. PubMed ID: 31773516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANO1-Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer-Associated Fibroblasts.
    Jiang F; Jia K; Chen Y; Ji C; Chong X; Li Z; Zhao F; Bai Y; Ge S; Gao J; Zhang X; Li J; Shen L; Zhang C
    Adv Sci (Weinh); 2023 Aug; 10(24):e2300881. PubMed ID: 37341301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival.
    Zhao J; Soto LMS; Wang H; Katz MH; Prakash LR; Kim M; Tzeng CD; Lee JE; Wolff RA; Huang Y; Wistuba II; Maitra A; Wang H
    Pancreatology; 2021 Aug; 21(5):942-949. PubMed ID: 33832821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
    Guo XJ; Lu JC; Zeng HY; Zhou R; Sun QM; Yang GH; Pei YZ; Meng XL; Shen YH; Zhang PF; Cai JB; Huang PX; Ke AW; Shi YH; Zhou J; Fan J; Chen Y; Yang LX; Shi GM; Huang XY
    Front Immunol; 2021; 12():705378. PubMed ID: 34526987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration.
    Liu S; Foulkes WD; Leung S; Gao D; Lau S; Kos Z; Nielsen TO
    Breast Cancer Res; 2014 Sep; 16(5):432. PubMed ID: 25193543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma.
    Suzuki J; Aokage K; Neri S; Sakai T; Hashimoto H; Su Y; Yamazaki S; Nakamura H; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Tsuboi M; Ishii G
    Lung Cancer; 2021 Mar; 153():1-10. PubMed ID: 33429158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA‑144 suppresses aggressive phenotypes of tumor cells by targeting ANO1 in colorectal cancer.
    Jiang Y; Cai Y; Shao W; Li F; Guan Z; Zhou Y; Tang C; Feng S
    Oncol Rep; 2019 Apr; 41(4):2361-2370. PubMed ID: 30816505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer.
    Chen Q; Pu N; Yin H; Zhang J; Zhao G; Lou W; Wu W
    J Cell Mol Med; 2020 Aug; 24(15):8674-8686. PubMed ID: 32643277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.
    Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW
    Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.